MoHAP introduces Rezum Therapy to treat enlarged prostate without surgical intervention

▴ mohap-introduces-fda-approved-rezum-therapy-treat-enlarged-prostate-without-surgical-intervention
Rezūm therapy is a new option for patients who are dissatisfied with their current choices for treating BPH

Al Qassimi Hospital in Sharjah at the Ministry of Health and Prevention, MoHAP, has introduced for the first time in the UAE the FDA-approved Rezūm therapy to treat the enlarged prostate without surgical intervention. The revolutionary Rezūm treatment takes only 5-10 seconds to complete.

“As part of our commitment to mitigating patients’ pain and changing their lives to the better, we strive to enhance innovation and excellence, adopt the best treatments in hospitals, attract the latest medical technology, raise the competence of our medical cadres, provide the best diagnostics and therapeutics, and implement standards of quality and distinction,” said HE Dr Youssif Al Serkal, Director-General of the Emirates Health Services Corporation and Assistant Undersecretary for the Hospital Sector.

This comes as part of MoHAP’s efforts to deliver a world-class healthcare system and achieve leadership in the health field.

Dr Kalthoum Al Baloushi, Director of MoHAP’s Hospitals Administration said the RezÅ«m therapy is a qualitative addition to Al Qassimi Hospital services thanks to MoHAP’s unlimited support and the provision of best resources to upskill the quality of health services and patient safety, lauding the competence of the medical staff and their ability to deal with critical cases, stressing the Hospitals Administration’s eagerness to further develop the health services and achieve quality and excellence in MoHAP’s hospitals.

Dr Arif Al Nooryani, the CEO of Al Qassimi Hospital, pointed to MoHAP’s keenness to provide the latest medical innovations and offer patients an ideal healthcare service.

“The Urology Department brings together a professional, competent, and highly skilled medical staff and is equipped with the latest technologies to provide an effective and safe treatment for patients,”

Al Nooryani added: “There’s no need any more for travelling abroad to receive this new therapy. This would help save patient’s time, effort, and money, thanks to MoHAP’s keenness to bring in the modern technologies and therapeutics to its health facilities for the health of community members.”

Dr Younis Al Shamsi, Consultant Urologist and Head of the Urology Department, Al Qassimi Hospital, said: “The RezÅ«m therapy is a safe technology and unpainful procedure. During the procedure, the urologist inserts a small narrow device through the urethra to deliver water vapour directly into the enlarged prostate tissue. For years, the primary options for treating prostate enlargement were through medications or surgery, making RezÅ«m a new option for patients who are dissatisfied with their current choices for treating BPH,”

Tags : #MoHAP #FDAApprovedRezumTherapy #AlQassimiHospitalSharjah #DrKalthoumAlBaloushi #DrYounisAlShamsi

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Successful Removal of 3.7 KG Large Abdominal Tumor from 14-Year-Old Somalian Girl at KIMS Cuddles HospitalMay 16, 2024
iLEAD Sets a Precedent by Launching a Graphic Anthology Authored by Multimedia, Animation and Graphics Students May 16, 2024
Ramaiah Memorial Hospital Launches Novel Intra-Operative Radiation Therapy (IORT); Achieves significant advancement in Cancer Treatment to Enhance Quality of LifeMay 16, 2024
IIITH Announces Product Management Summer SchoolMay 16, 2024
Çelebi India's Delhi Cargo Terminal Successfully Handles Airbus H125 Helicopter ShipmentMay 16, 2024
Plant-Based Diets and Prostate Cancer: New UCSF Study Shows Promising ResultsMay 16, 2024
National Medical Commission Approves 112 New Medical CollegesMay 16, 2024
Study Suggests That Chemotherapy Results in Physical Decline for Older Women with Breast CancerMay 16, 2024
Google DeepMind's AlphaFold 3: Revolutionizing Drug Discovery with AIMay 16, 2024
Hester Biosciences Ltd reports Consolidated Revenue growth of 18% at Rs. 79.3 crore, EBITDA up 37% to Rs. 16.4 crore and Net Profit up 12% to Rs. 6.40 crore in Q4FY24May 16, 2024
Akshay Tritiya Parna Mahotsav heldMay 16, 2024
IT Minister Sridhar Babu to grace the 10th National Facilities Managers Summit-2024, to be held in the cityMay 15, 2024
Alarming Study Reveals Cancer-Causing Chemicals in Car InteriorsMay 15, 2024
India's Thalassemia Challenge: The Importance of Early Screening and TreatmentMay 15, 2024
The Dangers of Ultra-Processed Foods: A 30-Year Study Raises AlarmsMay 15, 2024
Unique Genetic Risk Factors for Breast Cancer Found in African Ancestry StudyMay 15, 2024
AsiaMedic partners with Sunway to establish new diagnostic imaging centreMay 14, 2024
Kamineni Doctors Successfully Remove Bone Stuck Near Heart in Elderly PatientMay 14, 2024
On International Nurses Day, American Oncology Institute (AOI) launches #TheExtraordinaryCareGiver Campaign as Tribute to Oncology NursesMay 14, 2024
Shiprocket announces Shiprocket Growth Academy to upskill 100,000 Indian MSMEs through eCommerce learningMay 14, 2024